Overview

Basic information

Litigation

Active legal matters

Material Events

8-K disclosures

SEC Filings

Key regulatory docs

Insider Transactions

Ownership changes

Overview

Basic information

Litigation

Active legal matters

Material Events

8-K disclosures

SEC Filings

Key regulatory docs

Insider Transactions

Ownership changes

ANTARES PHARMA, INC. (ATRS) Class Action Lawsuit (October 2017)

Closed

21-1624 • October 23, 2017

Class Period Start

December 21, 2016

Class Period End

October 12, 2017

PSLRA Deadline

December 22, 2017

Case Allegations

10b5

Statutes of Repose

Dec 21, 2019

Country

United States

Court

Federal Court

Docket History

Mar 29, 2021

On Appeal

Feb 26, 2021

Motion to Dismiss Granted

The court has granted the defendants' request to dismiss the lawsuit. Depending on the court's decision, the plaintiffs may be allowed to file an updated complaint or pursue an appeal.

Jul 10, 2020

Motion to Dismiss

After reviewing the complaint(s) filed by plaintiffs, defendants have filed a motion requesting that the court dismiss some or all of the plaintiffs' claims. In a motion to dismiss, defendants might challenge the validity of plaintiffs' claims or adequacy of plaintiffs' pleadings. Once a motion to dismiss is filed, the judge will make a decision on whether part or all of the case should be dismissed or the case can proceed as alleged.

Jul 10, 2020

Motion to Dismiss

After reviewing the complaint(s) filed by plaintiffs, defendants have filed a motion requesting that the court dismiss some or all of the plaintiffs' claims. In a motion to dismiss, defendants might challenge the validity of plaintiffs' claims or adequacy of plaintiffs' pleadings. Once a motion to dismiss is filed, the judge will make a decision on whether part or all of the case should be dismissed or the case can proceed as alleged.

Jun 10, 2020

Scheduling Order

May 29, 2020

Third Amended Complaint

A new complaint has been filed on behalf of certain investors in ANTARES PHARMA, INC.. Amended complaints may contain additional facts, parties, allegations, a change in the class definition, etc.

Apr 28, 2020

Scheduling Order

Apr 28, 2020

Motion to Dismiss Granted

The court has granted the defendants' request to dismiss the lawsuit. Depending on the court's decision, the plaintiffs may be allowed to file an updated complaint or pursue an appeal.

Sep 12, 2019

Motion to Dismiss

After reviewing the complaint(s) filed by plaintiffs, defendants have filed a motion requesting that the court dismiss some or all of the plaintiffs' claims. In a motion to dismiss, defendants might challenge the validity of plaintiffs' claims or adequacy of plaintiffs' pleadings. Once a motion to dismiss is filed, the judge will make a decision on whether part or all of the case should be dismissed or the case can proceed as alleged.

Aug 5, 2019

Scheduling Order

Jul 29, 2019

Second Amended Complaint

A new complaint has been filed on behalf of certain investors in ANTARES PHARMA, INC.. Amended complaints may contain additional facts, parties, allegations, a change in the class definition, etc.

Jun 30, 2019

Motion to Dismiss Granted

The court has granted the defendants' request to dismiss the lawsuit. Depending on the court's decision, the plaintiffs may be allowed to file an updated complaint or pursue an appeal.

Nov 26, 2018

Motion to Dismiss

After reviewing the complaint(s) filed by plaintiffs, defendants have filed a motion requesting that the court dismiss some or all of the plaintiffs' claims. In a motion to dismiss, defendants might challenge the validity of plaintiffs' claims or adequacy of plaintiffs' pleadings. Once a motion to dismiss is filed, the judge will make a decision on whether part or all of the case should be dismissed or the case can proceed as alleged.

Aug 8, 2018

Scheduling Order

Jul 27, 2018

Appointment of Lead Plaintiff

The court has appointed a lead plaintiff to represent the interests of investors in the lawsuit. The lead plaintiff works with the attorneys handling the case, helps oversee the litigation, and represents the interests of the proposed class.

Oct 23, 2017

First Filed Complaint

A securities fraud class action complaint has been filed on behalf of certain investors in ANTARES PHARMA, INC..

TOP